BIB
$58.09
ProShares Ultra Nasdaq Biotechnology
Fund Family: ProShares Trust
Explore sections
Top 10 Holdings
Largest positions representing 49.3% of the portfolio
49.3%
of portfolio
Loading chart...
- United States of AmericaManufacturing10.14%
- Gilead Sciences IncManufacturing6.41%
- Amgen IncManufacturing6.23%
- Vertex Pharmaceuticals IncManufacturing6.13%
- MOTION FINCO SARLManufacturing4.50%
- Regeneron Pharmaceuticals IncManufacturing4.38%
- AstraZeneca PLCManufacturing3.52%
- Alnylam Pharmaceuticals IncManufacturing3.27%
- Invesco Government & Agency PortfolioUnknown3.12%
- Biogen IncManufacturing1.58%
| Rank | Company | Ticker | Sector | Weight (%) |
|---|---|---|---|---|
1 | United States of America 912797NV5 | B | Manufacturing | 10.14% |
2 | Gilead Sciences Inc 375558103 | GILD | Manufacturing | 6.41% |
3 | Amgen Inc 031162100 | AMGN | Manufacturing | 6.23% |
4 | Vertex Pharmaceuticals Inc 92532F100 | VRTX | Manufacturing | 6.13% |
5 | MOTION FINCO SARL 000000000 | 000000000 | Manufacturing | 4.50% |
6 | Regeneron Pharmaceuticals Inc 75886F107 | REGN | Manufacturing | 4.38% |
7 | AstraZeneca PLC 046353108 | AZN | Manufacturing | 3.52% |
8 | Alnylam Pharmaceuticals Inc 02043Q107 | ALNY | Manufacturing | 3.27% |
9 | Invesco Government & Agency Portfolio 825252885 | AGPXX | Unknown | 3.12% |
10 | Biogen Inc 09062X103 | BIIB | Manufacturing | 1.58% |